Qualitek LabsBOM:544091 -1.66%46 Net Margin % is 13.99% as of Mar. 2026, which is 35% above its 10-year median of 10.35. GuruFocus rates BOM:544091 with a GF Score™ of 46/100. The stock has 5 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, Qualitek Labs ranks better than 81.77% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Qualitek Labs's Net Income for the
six
months ended in Mar. 2026 was ₹98 Mil. Qualitek Labs's Revenue for the
six
months ended in Mar. 2026 was ₹703 Mil. Therefore, Qualitek Labs's net margin for the quarter that ended in Mar. 2026 was 13.99%.
The historical rank and industry rank for Qualitek Labs's Net Margin % or its related term are showing as below:
BOM:544091'
s Net Margin % Range Over the Past 10 Years
Min: 2.41 Med: 10.35 Max: 15.39
Current: 11.73
BOM:544091's Net Margin % is ranked better than 81.77% of 203
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.69
vs BOM:544091: 11.73
Qualitek Labs (BOM:544091) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Qualitek Labs Net Margin % Related Terms
Qualitek Labs Net Margin % Historical Data
* Premium members only.
The historical data trend for Qualitek Labs's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544091 vs TMO, DHR, IDXX: Net Margin % Comparison
For the Diagnostics & Research subindustry, Qualitek Labs's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qualitek Labs Net Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Qualitek Labs's Net Margin % distribution charts can be found below:
* The bar in red indicates where Qualitek Labs's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qualitek Labs (BOM:544091) has a Net Margin % of 13.99% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Qualitek Labs and its competitors. This is 35% above median its historical median of 10.35. Over the past decade, Qualitek Labs' Net Margin % has ranged from 2.41 to 15.39. According to the industry distribution chart, Qualitek Labs ranks #37 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 18.2%.
Is Qualitek Labs' Net Margin % too high?
Qualitek Labs' current Net Margin % of 13.99% is 35% above median its 10-year median of 10.35. Over the past 10 years, this metric has ranged from a low of 2.41 to a high of 15.39. Based on the distribution chart, Qualitek Labs ranks #37 out of 203 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Qualitek Labs has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Qualitek Labs' Net Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Qualitek Labs ranks #37 out of 203 companies for Net Margin %. This places Qualitek Labs in the top 18% of its industry — outperforming the majority of peers. Historically, Qualitek Labs' own Net Margin % has ranged from 2.41 to 15.39 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Qualitek Labs and its competitors. Qualitek Labs's current Net Margin % is 13.99%, which is 35% above median its own 10-year median of 10.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qualitek Labs stock overvalued right now?
Qualitek Labs (BOM:544091) has a current Net Margin % of 13.99%. The current Net Margin % is 13.99%, which is 35% above median its 10-year median of 10.35. Qualitek Labs' overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Qualitek Labs (BOM:544091), the current Net Margin % is 13.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Qualitek Labs Ltd is engaged in the business of providing testing, inspection, homologation, certification, and consultancy services to various industries such as automotive, defence, metals & metallurgy, environment and water, minerals, food & agriculture, pharma & healthcare.
46GF Score
Get the complete analysis for BOM:544091
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544091 has been successfully added to your 
